Taro Pharmaceutical Industries Ltd (TARO)
42.30
-0.11
(-0.26%)
USD |
NYSE |
May 10, 16:00
42.26
-0.04
(-0.09%)
After-Hours: 20:00
Taro Pharmaceutical Industries Free Cash Flow: 86.00M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
December 31, 2023 | 86.00M |
September 30, 2023 | 94.52M |
June 30, 2023 | 72.97M |
March 31, 2023 | 11.90M |
December 31, 2022 | -97.03M |
September 30, 2022 | -297.23M |
June 30, 2022 | -370.22M |
March 31, 2022 | -270.02M |
December 31, 2021 | -160.97M |
September 30, 2021 | 71.83M |
June 30, 2021 | 9.77M |
March 31, 2021 | 28.62M |
December 31, 2020 | 21.94M |
September 30, 2020 | 76.30M |
June 30, 2020 | 227.50M |
March 31, 2020 | 243.19M |
December 31, 2019 | 251.73M |
September 30, 2019 | 258.34M |
June 30, 2019 | 291.31M |
March 31, 2019 | 293.02M |
December 31, 2018 | 330.64M |
September 30, 2018 | 313.21M |
June 30, 2018 | 304.42M |
March 31, 2018 | 294.15M |
December 31, 2017 | 314.08M |
Date | Value |
---|---|
September 30, 2017 | 353.63M |
June 30, 2017 | 421.00M |
March 31, 2017 | 401.71M |
December 31, 2016 | 443.63M |
September 30, 2016 | 426.97M |
June 30, 2016 | 356.93M |
March 31, 2016 | 376.02M |
December 31, 2015 | 434.28M |
September 30, 2015 | 423.47M |
June 30, 2015 | 422.74M |
March 31, 2015 | 386.63M |
December 31, 2014 | 258.00M |
September 30, 2014 | 264.54M |
June 30, 2014 | 301.08M |
March 31, 2014 | 331.84M |
December 31, 2013 | 324.93M |
September 30, 2013 | 313.10M |
June 30, 2013 | 281.52M |
March 31, 2013 | 238.41M |
December 31, 2012 | 225.07M |
September 30, 2012 | 197.89M |
June 30, 2012 | 169.05M |
March 31, 2012 | |
December 31, 2011 | 175.11M |
September 30, 2011 | 145.63M |
Free Cash Flow Range, Past 5 Years
-370.22M
Minimum
Jun 2022
291.31M
Maximum
Jun 2019
28.97M
Average
71.83M
Median
Sep 2021
Free Cash Flow Benchmarks
InspireMD Inc | -16.76M |
BiomX Inc | -21.34M |
Alpha Tau Medical Ltd | -- |
Pluri Inc | -18.82M |
Holdco Nuvo Group DG Ltd | -- |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | 30.92M |
Cash from Investing (Quarterly) | 81.67M |
Free Cash Flow Per Share (Quarterly) | -0.0945 |
Free Cash Flow to Equity (Quarterly) | -3.553M |
Free Cash Flow to Firm (Quarterly) | -3.553M |
Free Cash Flow Yield | 5.41% |